News | August 24, 2025
Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The facility will be positioned as a Centre of Excellence for tertiary care services
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
Rivaroxaban is used to treat venous thromboembolism
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Subscribe To Our Newsletter & Stay Updated
